Exploring Lung Cancer Treatment Strategies within Brazil's Largest Private Health Insurance: Insights from Real-World Data

1

Lung cancer is the leading cause of cancer-related mortality in Brazil, with 30,200 new cases annually and a 5-year survival rate of only 18%.
2

This study analyzes lung cancer treatment patterns and outcomes within Brazil's largest private health insurance system, covering over 8.8 million individuals.
3

A total of 690 lung cancer patients were identified, with a median age of 67 years; 35.7% presented with stage IV disease.
4

Common comorbidities among patients included hypertension (62.5%), diabetes (39.0%), and COPD (24.3%), with 61.4% having a history of smoking.
5

The study highlights the need for improved access to precision oncology and better healthcare outcomes in Brazil's private health sector.

Bmc Cancer

by Rodrigo Afonso da Silva Sardenberg, Carlos Augusto Lima de Campos, Breno Cordeiro Porto, Jose Arnaldo Shiomi da Cruz
March 4, 2026

1